Xencor

Develops superior monoclonal antibody therapeutics to treat autoimmune disorders, asthma, allergic diseases and cancer.

Launch date

1997

Employees

Market cap

Enterprise valuation

CAD1.5b (Public information from Sep 2024)

Monrovia California (HQ)

http://xencor.com

https://twitter.com/xencor https://www.linkedin.com/company/xencor

View job openings

Authorizing premium user...